(3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride

Catalog No.: 
ACLTOS597
CAS No.: 
478922-47-3
Molecular Formula: 
C5H12ClNO2
Molecular Weight: 
153.61
(3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%
100g97%
500g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride
IUPAC Name(3R,5S)-5-(hydroxymethyl)pyrrolidin-3-ol hydrochloride
MDL No.MFCD09056830
Molecular FormulaC5H12ClNO2
Molecular Weight153.61
SMILESO[C@H]1CN[C@H](CO)C1.[H]Cl
InChI KeyIUHDMWJWUWKOFE-UYXJWNHNSA-N
SynonymEN300-153245 | (3R,5S)-5-HYDROXYMETHYL-3-PYRROLIDINOLHCL | (3R,5S)-5-(Hydroxymethyl)pyrrolidin-3-ol--hydrogen chloride (1/1) | (3R,5S)-5-(hydroxymethyl)pyrrolidin-3-ol HCl | MFCD09056830 | AKOS024258488 | (3R,5S)-5-(Hydroxymethyl)pyrrolidine-3-ol HCl | (3
CAS No.478922-47-3
PubChem CID53487134

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLTOS597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXVZD634 route compound structure diagram
    ACXVZD63461478-26-0In Stock
  2. Then
  3. ACLTOS597 route product structure diagram
    ACLTOS597478922-47-3In Stock
Inquiry

2. ACLTOS597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVNCF261 route compound structure diagram
    ACVNCF26140216-83-9In Stock
  2. Then
  3. ACLTOS597 route product structure diagram
    ACLTOS597478922-47-3In Stock
Inquiry

3. ACLTOS597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRQUA805 route compound structure diagram
    ACRQUA80595687-41-5In Stock
  2. Then
  3. ACLTOS597 route product structure diagram
    ACLTOS597478922-47-3In Stock
Inquiry

Comments (0)